Neurology Alert – April 1, 2012
April 1, 2012
View Issues
-
Is Insulin a Potential Therapy for Alzheimer's Disease?
Preliminary trials of low-dose intranasal insulin suggest a possible benefit that warrants further investigation. -
REM Behavior Disorder as a Predictor of Mild Cognitive Impairment
REM behavior disorder can be reliably diagnosed using a simple bed-partner questionnaire and its presence is a risk factor for a future neurodegenerative disease. -
Differentiating Necrotizing Myositis from Polymyositis
Necrotizing myositis is a newly described inflammatory myopathy that has an autoimmune etiology and may be associated with anti-signal recognition particle autoantibodies. -
When is Brain Biopsy Indicated?
When a brain biopsy is being considered for a nonmalignant condition, the patients and the site of biopsy must be carefully selected to ensure the most useful results. -
Rasagiline for Motor Fluctuations in the Elderly with Parkinson's Disease
In a post-hoc analysis, rasagiline, as an adjunct to levodopa, is both efficacious in reducing "off" time and well-tolerated in individuals older than 70 years with moderate-to-advanced Parkinson's disease. -
Stroke Alert: A Review of Current Clinical Stroke Literature
Antihypertensive treatment reduces the incidence of headache compared to placebo, but the magnitude of the effect differs between drug classes independent of the magnitude of blood pressure reduction. Dysautoregulation in the anterior and posterior circulation is associated with migraine with aura. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Statins and diabetes risk; new treatment guideline for diabetes; new pertussis vaccine recommendation; antibiotics and rhinosinusitis; fluoroquinolones and cystitis; and FDA actions.